COVID-19 molecular testing in korea: Practical essentials and answers from experts based on experiences of emergency use authorization assays

  • on behalf of COVID-19 Diagnosis Test Management Committee established by Korea Centers for Disease Control and Prevention

Research output: Contribution to journalReview articlepeer-review

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection. Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide. Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention. However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions. Therefore, this guideline is intended as a practical and technical supplement to the “Guidelines for Laboratory Diagnosis of COVID-19 in Korea”.

Original languageEnglish
Pages (from-to)439-447
Number of pages9
JournalAnnals of Laboratory Medicine
Volume40
Issue number6
DOIs
StatePublished - 2020.11

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Coronavirus disease 2019
  • Guidelines
  • Korea
  • Laboratory diagnosis
  • Real-time RT-PCR

Fingerprint

Dive into the research topics of 'COVID-19 molecular testing in korea: Practical essentials and answers from experts based on experiences of emergency use authorization assays'. Together they form a unique fingerprint.

Cite this